Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 32 (3), 167-173
- https://doi.org/10.1016/j.tips.2010.12.006
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokersHypertension Research, 2010
- Deficiency of ROCK1 in bone marrow‐derived cells protects against atherosclerosis in LDLR −/− miceThe FASEB Journal, 2008
- Increased Rho Kinase Activity in a Taiwanese Population With Metabolic SyndromeJournal of the American College of Cardiology, 2007
- PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophagesThe EMBO Journal, 2007
- Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery DiseaseCirculation Research, 2006
- Inhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke ProtectionStroke, 2005
- Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent mannerThe Journal of Experimental Medicine, 2005
- The Rho-associated protein kinase p160ROCK is required for centrosome positioningThe Journal of cell biology, 2002